Insider Trading activities of Momenta Pharmaceuticals Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Momenta Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Momenta Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Momenta Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is MNTA. The reporting company's CIK number is 1235010.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $75,506,320.
The total value of stock option exercises since 2005 is $11,001,864.



Table 2. Detailed insider stock purchases, sales, and option exercises of Momenta Pharmaceuticals Inc insiders (MNTA) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-06-04 Wheeler Craig A (President) Option Ex 83,333 16.18 1,348,327
2015-06-01 Roach James M. (Senior VP, Development and Chi) Sale 25,000 21.70 542,500
2015-06-01 Roach James M. (Senior VP, Development and Chi) Option Ex 25,000 7.41 185,250
2015-06-01 Leicher Bruce (SVP & General Counsel) Sale 40,000 21.00 840,000
2015-06-01 Leicher Bruce (SVP & General Counsel) Option Ex 40,000 15.12 604,800
2015-05-26 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 254 19.80 5,029
2015-05-20 Roach James M. (Senior VP, Development and Chi) Sale 360 19.68 7,084
2015-05-20 Leicher Bruce (SVP & General Counsel) Sale 227 19.68 4,467
2015-05-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 227 19.68 4,467
2015-05-20 Shea Richard P (SVP, CFO) Sale 227 19.68 4,467
2015-05-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 19.68 4,467
2015-05-20 Wheeler Craig A (President) Sale 1,766 19.68 34,754
2015-05-19 Roach James M. (Senior VP, Development and Chi) Sale 617 19.63 12,111
2015-05-19 Leicher Bruce (SVP & General Counsel) Sale 426 19.63 8,362
2015-05-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 624 19.63 12,249
2015-05-19 Shea Richard P (SVP, CFO) Sale 406 19.63 7,969
2015-05-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 406 19.63 7,969
2015-05-19 Wheeler Craig A (President) Sale 2,061 19.67 40,539
2015-05-15 Roach James M. (Senior VP, Development and Chi) Sale 311 19.96 6,207
2015-05-15 Leicher Bruce (SVP & General Counsel) Sale 267 19.96 5,329
2015-05-15 Shea Richard P (SVP, CFO) Sale 145 19.96 2,894
2015-05-15 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 215 19.96 4,291
2015-05-15 Wheeler Craig A (President) Sale 1,766 19.92 35,178
2015-05-12 Clarke John K Sale 38,400 19.96 766,464
2015-05-12 Clarke John K Option Ex 38,400 10.44 400,896
2015-05-11 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 33,625 20.70 696,037
2015-05-11 Bishop John E (Senior VP, Pharmaceutical Scie) Option Ex 33,625 16.16 543,211
2015-05-06 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 493 19.05 9,391
2015-04-23 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 34,000 19.95 678,300
2015-04-23 Wheeler Craig A (President) Sale 51,667 20.00 1,033,340
2015-04-23 Wheeler Craig A (President) Option Ex 41,667 16.18 674,172
2015-04-20 Wheeler Craig A (President) Sale 6,269 18.75 117,543
2015-04-17 Leicher Bruce (SVP & General Counsel) Sale 12,910 18.05 233,025
2015-04-16 Roach James M. (Senior VP, Development and Chi) Sale 50,000 18.70 935,000
2015-04-16 Roach James M. (Senior VP, Development and Chi) Option Ex 50,000 7.41 370,500
2015-04-16 Leicher Bruce (SVP & General Counsel) Sale 40,000 20.00 800,000
2015-04-16 Leicher Bruce (SVP & General Counsel) Option Ex 40,000 15.12 604,800
2015-03-16 Shea Richard P (SVP, CFO) Sale 23,093 15.10 348,704
2015-03-11 Franken Michael (President, Biosimilars Busines) Sale 512 14.71 7,531
2015-03-05 Shea Richard P (SVP, CFO) Sale 23,364 14.90 348,123
2015-02-25 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 64 13.20 844
2015-02-24 Roach James M. (Senior VP, Development and Chi) Sale 192 13.56 2,603
2015-02-24 Leicher Bruce (SVP & General Counsel) Sale 192 13.56 2,603
2015-02-24 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 211 13.56 2,861
2015-02-24 Shea Richard P (SVP, CFO) Sale 192 13.56 2,603
2015-02-24 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 211 13.56 2,861
2015-02-24 Wheeler Craig A (President) Sale 2,110 13.52 28,527
2015-02-23 Roach James M. (Senior VP, Development and Chi) Sale 199 12.93 2,573
2015-02-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 129 12.93 1,667
2015-02-20 Roach James M. (Senior VP, Development and Chi) Sale 249 13.40 3,336
2015-02-20 Leicher Bruce (SVP & General Counsel) Sale 227 13.40 3,041
2015-02-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 227 13.40 3,041
2015-02-20 Shea Richard P (SVP, CFO) Sale 227 13.40 3,041
2015-02-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 13.40 3,041
2015-02-20 Wheeler Craig A (President) Sale 1,688 13.37 22,568
2015-02-19 Roach James M. (Senior VP, Development and Chi) Sale 1,664 12.91 21,482
2015-02-19 Leicher Bruce (SVP & General Counsel) Sale 1,664 12.91 21,482
2015-02-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 1,541 12.91 19,894
2015-02-19 Shea Richard P (SVP, CFO) Sale 1,585 12.91 20,462
2015-02-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 1,585 12.91 20,462
2015-02-19 Wheeler Craig A (President) Sale 7,875 13.52 106,470
2015-02-18 Roach James M. (Senior VP, Development and Chi) Sale 252 11.91 3,001
2015-02-18 Leicher Bruce (SVP & General Counsel) Sale 312 11.91 3,715
2015-02-18 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 252 11.91 3,001
2015-02-18 Shea Richard P (SVP, CFO) Sale 169 11.91 2,012
2015-02-18 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 252 11.91 3,001
2015-02-18 Wheeler Craig A (President) Sale 1,688 11.91 20,104
2015-02-11 Downey Bruce Option Ex 10,000 8.85 88,500
2015-01-16 Shea Richard P (SVP, CFO) Option Ex 11,250 6.88 77,400
2014-12-15 Shapiro Bennett M Sale 5,800 12.19 70,702
2014-12-11 Franken Michael (President, Biosimilars Busines) Sale 2,047 12.29 25,157
2014-12-10 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Option Ex 25,000 6.88 172,000
2014-12-01 Shapiro Bennett M Sale 9,903 12.00 118,836
2014-11-28 Shapiro Bennett M Sale 1,897 12.00 22,764
2014-11-26 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 64 11.60 742
2014-11-25 Roach James M. (Senior VP, Development and Chi) Sale 192 11.67 2,240
2014-11-25 Leicher Bruce (SVP & General Counsel) Sale 192 11.67 2,240
2014-11-25 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 211 11.67 2,462
2014-11-25 Shea Richard P (SVP, CFO) Sale 192 11.67 2,240
2014-11-25 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 211 11.67 2,462
2014-11-25 Wheeler Craig A (President) Sale 2,210 11.59 25,613
2014-11-24 Roach James M. (Senior VP, Development and Chi) Sale 199 11.53 2,294
2014-11-24 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 135 11.53 1,556
2014-11-20 Roach James M. (Senior VP, Development and Chi) Sale 250 11.13 2,782
2014-11-20 Leicher Bruce (SVP & General Counsel) Sale 228 11.13 2,537
2014-11-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 228 11.13 2,537
2014-11-20 Shea Richard P (SVP, CFO) Sale 228 11.13 2,537
2014-11-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 228 11.13 2,537
2014-11-20 Wheeler Craig A (President) Sale 1,768 11.10 19,624
2014-11-17 Roach James M. (Senior VP, Development and Chi) Sale 217 10.64 2,308
2014-11-17 Leicher Bruce (SVP & General Counsel) Sale 269 10.64 2,862
2014-11-17 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 217 10.64 2,308
2014-11-17 Shea Richard P (SVP, CFO) Sale 146 10.64 1,553
2014-11-17 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 217 10.64 2,308
2014-11-17 Wheeler Craig A (President) Sale 1,768 10.58 18,705
2014-10-17 Sulat James R Option Ex 5,000 8.85 44,250
2014-10-03 Shapiro Bennett M Sale 3,723 12.00 44,676
2014-09-12 Hutt Peter Barton Sale 3,640 11.42 41,568
2014-08-27 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 64 12.00 768
2014-08-25 Roach James M. (Senior VP, Development and Chi) Sale 192 11.45 2,198
2014-08-25 Leicher Bruce (SVP & General Counsel) Sale 192 11.45 2,198
2014-08-25 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 346 11.45 3,961
2014-08-25 Shea Richard P (SVP, CFO) Sale 192 11.45 2,198
2014-08-25 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 211 11.45 2,415
2014-08-25 Wheeler Craig A (President) Sale 2,209 11.45 25,293
2014-08-22 Roach James M. (Senior VP, Development and Chi) Sale 199 11.32 2,252
2014-08-20 Roach James M. (Senior VP, Development and Chi) Sale 250 11.54 2,885
2014-08-20 Leicher Bruce (SVP & General Counsel) Sale 228 11.54 2,631
2014-08-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 228 11.54 2,631
2014-08-20 Shea Richard P (SVP, CFO) Sale 228 11.54 2,631
2014-08-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 228 11.54 2,631
2014-08-20 Wheeler Craig A (President) Sale 1,768 11.54 20,402
2014-08-18 Shea Richard P (SVP, CFO) Sale 145 11.84 1,716
2014-08-15 Roach James M. (Senior VP, Development and Chi) Sale 217 11.75 2,549
2014-08-15 Leicher Bruce (SVP & General Counsel) Sale 268 11.75 3,149
2014-08-15 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 217 11.75 2,549
2014-08-15 Shapiro Bennett M Sale 3,722 12.00 44,664
2014-08-15 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 217 11.75 2,549
2014-08-15 Wheeler Craig A (President) Sale 1,768 11.75 20,774
2014-08-13 Shapiro Bennett M Sale 3,721 12.00 44,652
2014-05-27 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 64 12.24 783
2014-05-23 Roach James M. (Senior VP, Development and Chi) Sale 192 12.09 2,321
2014-05-23 Leicher Bruce (SVP & General Counsel) Sale 192 12.09 2,321
2014-05-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 346 12.09 4,183
2014-05-23 Shea Richard P (SVP, CFO) Sale 192 12.09 2,321
2014-05-23 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 211 12.09 2,550
2014-05-23 Wheeler Craig A (President) Sale 2,110 12.06 25,446
2014-05-22 Roach James M. (Senior VP, Development and Chi) Sale 199 11.74 2,336
2014-05-20 Roach James M. (Senior VP, Development and Chi) Sale 250 12.08 3,020
2014-05-20 Leicher Bruce (SVP & General Counsel) Sale 227 12.08 2,742
2014-05-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 227 12.08 2,742
2014-05-20 Shea Richard P (SVP, CFO) Sale 227 12.08 2,742
2014-05-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 12.08 2,742
2014-05-20 Wheeler Craig A (President) Sale 1,688 12.08 20,391
2014-05-15 Roach James M. (Senior VP, Development and Chi) Sale 217 11.09 2,406
2014-05-15 Leicher Bruce (SVP & General Counsel) Sale 269 11.09 2,983
2014-05-15 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 217 11.09 2,406
2014-05-15 Shea Richard P (SVP, CFO) Sale 146 11.09 1,619
2014-05-15 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 217 11.09 2,406
2014-05-15 Wheeler Craig A (President) Sale 1,687 11.09 18,708
2014-04-15 Roach James M. (Senior VP, Development and Chi) Sale 485 10.76 5,218
2014-03-21 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Option Ex 31,200 4.91 153,192
2014-03-04 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 64 14.41 922
2014-02-27 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 211 17.49 3,690
2014-02-25 Roach James M. (Senior VP, Development and Chi) Sale 192 17.47 3,354
2014-02-25 Leicher Bruce (SVP & General Counsel) Sale 192 17.47 3,354
2014-02-25 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 277 17.47 4,839
2014-02-25 Shea Richard P (SVP, CFO) Sale 192 17.47 3,354
2014-02-25 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 211 17.47 3,686
2014-02-25 Wheeler Craig A (President) Sale 2,109 17.47 36,844

Insider trading activities including stock purchases, stock sales, and option exercises of MNTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Momenta Pharmaceuticals Inc (symbol MNTA, CIK number 1235010) see the Securities and Exchange Commission (SEC) website.